| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/17/2005 | WO2005014553A1 Novel gamma-secretase inhibitors |
| 02/17/2005 | WO2005014552A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/17/2005 | WO2005014540A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 02/17/2005 | WO2005013977A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004110993A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/17/2005 | WO2004110344A3 New azetidine compounds |
| 02/17/2005 | WO2004092115A3 Hydroxamates as therapeutic agents |
| 02/17/2005 | WO2004084813A3 Chemical compounds |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038243 2, 4-pyrimidinediamine compounds and their uses |
| 02/17/2005 | US20050038101 Substituted 2 5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 02/17/2005 | US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia |
| 02/17/2005 | US20050038099 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process |
| 02/17/2005 | US20050038092 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species; side effect reductions |
| 02/17/2005 | US20050038089 Thiazole derivatives |
| 02/17/2005 | US20050038087 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 02/17/2005 | US20050038086 Epothilone derivatives and methods for making and using the same |
| 02/17/2005 | US20050038078 Antimetastasis agents e.g. 6-[4-Amino-5-(2,6-difluoro-benzoyl)-thiazol-2-ylamino]-N-pyridin-2-ylmethyl-nicotinamide; protein kinase inhibitor |
| 02/17/2005 | US20050038075 Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives |
| 02/17/2005 | US20050038074 Kinesin spindle protein (KSP) inhibitors, e.g., 4-(2,5-Difluorophenyl)-N-[(3S,4S)-3-fluoropiperidin-4-yl]-2-hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1N-pyrrole-1-carboxamide; antiproliferative and -carcinogenic agents |
| 02/17/2005 | US20050038073 Thiazole derivatives |
| 02/17/2005 | US20050038072 Nitrogeneous cyclic ketone derivative, process for producing the same, and use |
| 02/17/2005 | US20050038069 Tumor necrosis factor antagonist; antiinflammatory agents; such as 2-Cyclopropyl-4-(3,5-dimethyl-4-pyridylmethoxy)-7-methoxy-3H-benzimidazole |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038059 N-{4-[2-(1-Dimethylamino-ethylimino)-4-phenyl-thiazol-5-yl]-pyrimidin-2-yl}-N-phenyl-amine; fungicides against infestation by phytopathogenic organisms, nematodes, insects, fungi, bacteria, viruses |
| 02/17/2005 | US20050038040 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders |
| 02/17/2005 | US20050038038 N-phenyl substituted carbamoyloxyalkyl-azolium derivatives |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038031 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 02/17/2005 | US20050038029 Transferring, releasing nitric oxide; side effect reduction; using a compound containing nitrosos group |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | US20050038016 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 02/17/2005 | US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/17/2005 | US20050037925 Mixture with other herbicides |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534405A1 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 02/17/2005 | CA2534057A1 Novel gamma-secretase inhibitors |
| 02/17/2005 | CA2533976A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/17/2005 | CA2533464A1 Thiazole derivatives as npy antagonists |
| 02/17/2005 | CA2533463A1 2-amino-5-benzoylthiazole npy antagonists |
| 02/17/2005 | CA2532452A1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506203A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/16/2005 | EP1506197A1 Acyl bicyclic derivatives of pyrrol |
| 02/16/2005 | EP1506189A1 Pyrrole derivatives as inhibitors of erk2 and uses thereof |
| 02/16/2005 | EP1506179A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 02/16/2005 | EP1506176A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/16/2005 | EP1505977A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1240166B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582284A Aminopyrimidines and pyridines |
| 02/16/2005 | CN1582281A Mch受体拮抗剂 Mch receptor antagonist |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/16/2005 | CN1582148A Derivatives of phenoxy-n-'4-(isothiazolidin-1, 1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu |
| 02/16/2005 | CN1580179A White electroluminescent polymer material and its preparing method |
| 02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
| 02/16/2005 | CN1189469C 3-(heteroaryl acetamido)-2-oxo-azeridine-1-sulfonic acid derivatives as anti-bacterial agents |
| 02/16/2005 | CN1189468C Preparation method of 5-[4-[2-(5-ethyl-2-pyridine)ethoxy]benzylidene]-2, 4thiazolidine diketone |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/10/2005 | WO2005012298A1 Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012295A1 Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same |
| 02/10/2005 | WO2005012294A1 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012288A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | WO2005012281A1 Neuroprotective benzo[1,3]oxathol-2-ones |
| 02/10/2005 | WO2005012275A2 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 02/10/2005 | WO2005012272A1 Benzoxazepine compound |
| 02/10/2005 | WO2005012271A2 Process for the synthesis of biaryl oxazolidinones |
| 02/10/2005 | WO2005012263A1 5-ht2b receptor antagonists |
| 02/10/2005 | WO2005012252A1 Novel 6-phenylphenantridines |
| 02/10/2005 | WO2005011812A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibithors |
| 02/10/2005 | WO2005011693A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 02/10/2005 | WO2005011686A1 2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as p13 kinase ihibitors |
| 02/10/2005 | WO2005011681A1 Chemical compounds |
| 02/10/2005 | WO2005011611A2 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | WO2005011601A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 02/10/2005 | WO2004060305A3 Anti-cancer medicaments |
| 02/10/2005 | WO2003099793A9 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 02/10/2005 | US20050033059 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032868 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032861 Antibiotic (vancomycin) resistant Grampositive and Gramnegative bacteria; cycloadditon, reduction, coupling, salt formation, deprotecting, amination, oxidation |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |